IA

Invemed Associates

North America, New York, United States, New York

Description

Invemed Associates is a merchant banking and investment banking firm

Investor Profile

Invemed Associates has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (33%)
  • Series A (33%)
  • Series E (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Health Diagnostics
  • Therapeutics
  • Data Integration
  • Electronics
  • Outsourcing
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Invemed Associates frequently co-invest with?

TC
North America, California, United States, Sausalito
Co-Investments: 1
Charlesbank Capital Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
WA
North America, New York, United States, New York
Co-Investments: 1
WC
North America, Texas, United States, Austin
Co-Investments: 1
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 2

What are some of recent deals done by Invemed Associates?

Xenogen Corporation

Alameda, California, United States

Xenogen Corporation is an integrated system of instruments and equipment, software and reagents to academic and biopharmaceutical

BiotechnologyGeneticsHealth CareHealth DiagnosticsTherapeutics
Series EMay 1, 2000
Amount Raised: $30,574,980
Advanced Data Exchange

Fremont, California, United States

Advanced Data Exchange provides electronic data interchange, business integration and commerce management services for businesses.

Data IntegrationElectronicsOutsourcingSoftware
Series AOct 25, 1999
Amount Raised: $6,500,000
Xenogen Corporation

Alameda, California, United States

Xenogen Corporation is an integrated system of instruments and equipment, software and reagents to academic and biopharmaceutical

BiotechnologyGeneticsHealth CareHealth DiagnosticsTherapeutics
Series DMay 3, 1999
Amount Raised: $11,020,005